Sorry, but you need a new version of this browser to see this web

Update Internet Explorer

Oncology

Eisai positions oncology as one of its therapeutic areas of focus, and continues to increase its commitment to oncology area through research and development of treatments for cancer and palliative therapies as well as the improvement of manufacturing capabilities.

Currently, Eisai is exploring several compounds with clinical studies enrolling in breast cancer, soft tissue sarcoma – liposarcoma subtype, differentiated thyroid carcinoma, renal cell carcinoma, hepatocellular carcinoma and a variety of other cancers and conditions. Eisai has a diverse in-house pipeline of oncology compounds in development and several more about to begin clinical trials for safety and efficacy evaluation.

 

Thank you for browsing the Eisai website.
You are about to visit an external website.
(A new browsing window will be opened)

Gracias por navegar por la web de Eisai.
Estás a punto de visitar una web externa.
(Se abrirá una nueva ventana de navegación)